A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
2024年11月22日
2.1K 次观看
The needle method of asymmetric bilateral common carotid artery stenosis is proposed to create a mouse model for vascular cognitive impairment and dementia. It results in longer-term outcomes compared to previously established models and is compatible with live MRI. Visual representation demonstrating the procedure provides guidance for mastering the surgery.
Overview
This study introduces a novel mouse model for vascular cognitive impairment and dementia (VCID) using the needle method of asymmetric bilateral common carotid artery stenosis. This model allows for extended monitoring through live MRI and provides insights into the mechanisms underlying VCID, particularly the role of inflammation.
Key Study Components
Area of Science
- Neuroscience
- Vascular biology
- Cognitive impairment
Background
- Understanding vascular cognitive impairment and dementia is critical due to its complex nature.
- Current models have limitations in dynamic monitoring and cost-efficiency.
- Inflammation is a significant factor contributing to VCID.
Purpose of Study
- To develop a reliable mouse model for studying VCID.
- To establish a method that allows live monitoring of brain activity using MRI.
- To investigate how inflammation affects VCID and potential interventions.
Methods Used
- The needle method of carotid artery stenosis was implemented in mice.
- The model focuses on vascular cognitive impairment and dementia.
- Surgical steps were detailed to ensure reproducibility and reliability of the model.
- Post-surgery monitoring included brain imaging and behavioral testing over 24 weeks.
Main Results
- Two-dimensional laser speckle imaging revealed sustained cerebral hypoperfusion.
- MRI indicated structural damage in ABCS mice with significant learning and memory impairments.
- The model demonstrated a survival rate of 81.6% over six weeks post-surgery.
Conclusions
- The newly developed model demonstrates effective monitoring of VCID over time.
- This approach aids in understanding the relationship between inflammation and cognitive decline.
- The findings may pave the way for therapeutic interventions against VCID.
Frequently Asked Questions
What are the advantages of the ABCS model?
The ABCS model allows for extended monitoring of brain activity and has a high survival rate, making it reliable for studying VCID.
How is the surgical procedure implemented?
The surgery involves blunting needle fragments, anesthesia, and precise surgical techniques to create stenosis in the carotid arteries.
What types of data are obtained from this model?
Data includes MRI imaging results, behavioral assessments like the Morris water maze, and measurements of cerebral blood flow.
How can this method be adapted for different studies?
Researchers can modify the parameters of stenosis and monitoring techniques based on their specific research goals.
What limitations should be considered with this model?
Researchers should be aware of the initial mortality rate and the need for skilled surgical technique to ensure model success.
Executive Industry Relevance
Robust animal models that recapitulate human vascular cognitive impairment and dementia (VCID) are essential for de-risking early-stage neurovascular drug discovery. The needle-guided asymmetric bilateral common carotid artery stenosis (ABCS) mouse model enables persistent, quantifiable cognitive deficits and white matter injury, supporting predictive confidence in target validation and mechanistic studies. Its compatibility with live MRI and high survival rate position it as a strategic platform for translational research and portfolio triage in neurovascular R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neurovascular mechanisms underlying VCID and cognitive decline.
- Supports functional target validation by modeling chronic cerebral hypoperfusion and inflammation.
- Facilitates predictive de-risking of therapeutic hypotheses in a disease-relevant system.
Screening & Assay Development
- Provides a reproducible in vivo platform for evaluating candidate interventions targeting VCID pathology.
- Allows for standardized behavioral and imaging endpoints, supporting quantitative assay development.
- Enables longitudinal assessment of intervention efficacy using MRI and cognitive testing.
Translational & Preclinical Research
- Aligns with human VCID pathogenesis, supporting translational biomarker discovery and validation.
- Maintains persistent cognitive and structural deficits, enabling risk-adjusted advancement decisions.
- Facilitates continuity from mechanistic discovery to preclinical efficacy studies.
Pipeline & Workflow Integration
The ABCS model bridges early discovery and preclinical validation by enabling hypothesis testing, mechanistic de-risking, and quantitative assessment of candidate interventions in a disease-relevant context.
- Discovery Biology: Supports mechanistic studies of hypoperfusion, inflammation, and cognitive impairment in VCID.
- Screening: Provides standardized behavioral and imaging readouts for compound evaluation.
- Analytics: Delivers quantitative MRI, laser speckle imaging, and cognitive metrics for cross-condition comparison.
- Translational Research: Aligns with clinical VCID features, supporting biomarker and therapeutic validation.
- Enterprise Reuse: Offers a scalable, low-cost, and MRI-compatible platform for diverse neurovascular research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in VCID research.
- Operational Value: Enhances reproducibility, standardization, and scalability of in vivo neurovascular studies.
- Strategic Value: Improves go/no-go decision-making and capital efficiency in neurovascular portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of VCID-targeted assets.
Implementation Considerations
- Requires advanced microsurgical expertise due to the fragility of mouse carotid arteries.
- Necessitates access to MRI and laser speckle imaging infrastructure for longitudinal monitoring.
- Demands rigorous cross-team standardization of surgical and behavioral protocols.
- Adaptable to various research needs by tuning stenosis parameters and monitoring endpoints.
- Initial post-surgical mortality and technical complexity must be managed for consistent outcomes.
Biopharma FAQs
Why does null hypothesis testing matter for VCID target validation?
Null hypothesis testing in the ABCS mouse model enables rigorous evaluation of whether candidate interventions truly impact cognitive and structural endpoints relevant to VCID, reducing false positives in target validation and supporting robust portfolio decisions.
How does independent variable isolation fit the ABCS model discovery pipeline?
The ABCS model allows precise manipulation of stenosis severity and timing, enabling isolation of specific vascular and inflammatory variables to clarify their mechanistic roles in VCID pathogenesis and therapeutic response.
What do quantitative dependent variable measurements enable in ABCS studies?
Quantitative MRI, laser speckle imaging, and behavioral metrics provide objective endpoints for comparing intervention effects, supporting reproducibility and cross-study benchmarking in neurovascular drug discovery.
Why are replication requirements critical for cross-functional VCID research?
Replication of ABCS model outcomes across teams ensures reliability of cognitive and imaging endpoints, facilitating cross-functional collaboration and confidence in translational findings for VCID programs.
Which statistical analysis capabilities are required before ABCS model implementation?
Robust statistical analysis of behavioral, imaging, and survival data is essential to validate model consistency, assess intervention efficacy, and inform go/no-go decisions in VCID-focused R&D pipelines.
